Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange.
Carol J LevyNicole C FosterStephanie N DuBoseShivani AgarwalSarah K LyonsAnne L PetersGabriel I UwaifoLinda A DiMeglioJennifer L SherrSarit PolskyPublished in: Journal of diabetes science and technology (2020)
Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed.